| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
Vascular endothelial growth factor A (VEGFA) stands as a master regulator of angiogenesis, orchestrating blood vessel formation in both physiological development and pathological conditions. This secreted signaling protein drives endothelial cell proliferation, migration, and survival, making it a focal point in cancer research where tumor-induced angiogenesis fuels disease progression. Beyond oncology, VEGFA plays critical roles in cardiovascular biology, metabolic regulation, and developmental processes, positioning it as a versatile target across multiple research disciplines.
This recombinant rabbit monoclonal antibody, clone 15A9, offers the reproducibility that demanding experimental workflows require. Generated against recombinant human VEGFA protein and produced through recombinant technology, it delivers sequence-defined consistency between lots, eliminating the variability that can compromise longitudinal studies or multi-site collaborations. The affinity-purified IgG format ensures minimal background while maintaining strong target recognition.
Validation studies demonstrate reliable performance across complementary detection platforms. Immunohistochemistry on paraffin-embedded human liver cancer tissue reveals clear VEGFA localization using citrate buffer antigen retrieval at dilutions between 1:50 and 1:200, providing flexibility to optimize signal intensity for your specific tissue context. Immunofluorescence applications have been validated in both HeLa and MCF7 cell lines at 1:30 dilution, with cytoplasmic staining patterns consistent with VEGFA's role as a secreted growth factor. This dual-platform validation gives researchers confidence when transitioning between tissue-based and cell-based experimental approaches.
Whether investigating tumor microenvironment dynamics, exploring developmental angiogenesis, or characterizing VEGFA expression in cardiovascular models, this antibody provides a dependable tool for advancing your research into this therapeutically significant target.
Email: support@cusabio.com
Distributors Worldwide